Mod GRF 1-29 Dosage Guide
Complete guide to Mod GRF 1-29 dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
100 mcg – 200 mcg
Frequency
3 times per day
Total Daily Dose
300 mcg – 600 mcg
Route
subcutaneous
Cycle Length
8–12 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Typical dosing
100-300mcg administered 2-3 times daily, usually combined with a GHRP like Ipamorelin for synergistic effects.
Administration Method
Subcutaneous injection. Best administered on empty stomach. Short half-life (~30 minutes) necessitates multiple daily doses, unlike DAC version.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.060 ml
Syringe units: 6.0 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with Mod GRF 1-29 defaults. Adjust values as needed.
Side Effects to Monitor
Flushing, headache, dizziness, and injection site reactions. Generally well-tolerated. May cause water retention.
Safety Considerations & Risks
Not FDA approved. May affect blood glucose. Long-term effects on pituitary function not fully characterized.